Clinical trial
Short-term Effects of Aromatase Inhibition in Obese Men
NCT00138710 · Rijnstate Hospital, Other · Completed
Key facts
| NCT number | NCT00138710 |
|---|---|
| Title | Short-term Effects of Aromatase Inhibition in Obese Men |
| Official title | Short-term Effects of Aromatase Inhibition in Obese Men |
| Lead sponsor | Rijnstate Hospital, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hypogonadotrophic Hypogonadism, Obesity |
| Intervention type | Drug |
| Interventions | Letrozole (Femara) |
| Enrollment | 50 |
| Start date | Aug 1, 2005 |
| Primary completion | Jan 1, 2010 |
| Completion | Jan 1, 2010 |
| First posted | Aug 30, 2005 |
| Last update posted | Oct 22, 2010 |
| Countries | Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: